Oscar Segurado, MD, PhDChief Medical Officer at ASC Therapeutics Inc.
Executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development and medical affairs.
Chief Medical Officer for ASC Therapeutics, formerly for Symvivo, Myriad Genetics-Crescendo and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie (Humira).
Senior medical leader experienced in in gene therapy, immuno-oncology, immuno-therapy, genomics and protein/cell diagnostics, predominantly focused on oncology, hematology and autoimmunity, including personalized medicine, molecular and cellular biomarkers.
Tenured Professorship of Immunology at the University of Leon, Spain, currently on leave. MD from the University of Salamanca, Spain, and PhD from the University of Wuerzburg, Germany.